LEDBURY HEALTH PARTNERSHIP
LEDBURY MARKET P/SHIP, MARKET STREET, LEDBURY
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 120 | 146 | 82.2% | |
| CKD 4 | 2008 | 181 | 225 | 80.4% | |
| CKD 5 | 2009 | 25 | 31 | 80.6% | |
| CKD 5 | 2010 | 2 | 2 | 100.0% | |
| CKD 5 | 2011 | 3 | 3 | 100.0% | |
| CKD 5 | 2012 | 6 | 6 | 100.0% | |
| CKD 5 | 2013 | 8 | 8 | 100.0% | |
| CKD003 | 2014 | 5 | 5 | 100.0% | |
| CKD003 | 2015 | 7 | 7 | 100.0% | |
| NM84 | 2016 | 7 | 9 | 77.8% | |
| NM84 | 2017 | 7 | 12 | 58.3% | |
| NM84 | 2018 | 6 | 13 | 46.2% | |
| NM84 | 2019 | 12 | 18 | 66.7% | |
| NM84 | 2020 | 8 | 17 | 47.1% | |
| NM84 | 2022 | 25 | 36 | 69.4% |
